亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

The relationship between statin therapy and adipocytokine/inflammatory mediators in dyslipidemic nondiabetic patients: A comparative study

医学 瑞舒伐他汀 阿托伐他汀 他汀类 内科学 PCSK9 血脂异常 脂蛋白 皮塔伐他汀 胆固醇 瑞舒伐他汀钙 药物治疗 C反应蛋白 治疗效果 血脂谱 炎症 内分泌学 胃肠病学 联合疗法 物理疗法
作者
Hany Akeel Al-Hussaniy,Ahmed Hamza Al-Shammari,Hayder Naji Sameer,Amjad I. Oraibi
出处
期刊:Фармация [Pensoft Publishers]
卷期号:70 (3): 581-585 被引量:21
标识
DOI:10.3897/pharmacia.70.e109800
摘要

Background : Statins have emerged as a vital therapeutic option for dyslipidemia, effectively reducing morbidity and mortality in individuals with various medical conditions. Recent research has shed light on the intricate pathophysiology of atherosclerosis, which involves lipid accumulation and inflammatory mediators. This research was conducted to assess the correlation between statin therapy and adipocytokine and inflammatory mediator levels in dyslipidemic nondiabetic patients. Methods : A total of 67 dyslipidemic nondiabetic patients were enrolled, alongside 33 healthy controls. The participants were categorized into three groups: Group (A), comprising patients undergoing statin therapy (n = 34), Group (B), consisting of patients not receiving statin therapy (n = 33); and Group (C), comprising healthy controls (n = 33). Results : Patients not receiving statin therapy exhibited significant dyslipidemic profiles compared to patients undergoing statin therapy and healthy controls. Levels of total cholesterol (TC), triglycerides (TG), very low-density lipoprotein (VLDL), and low-density lipoprotein (LDL) were higher in patients not receiving statin therapy. Serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) were higher in the statin group than in the non-statin group and controls. Additionally, PCSK9 levels were higher in patients treated with rosuvastatin than those treated with atorvastatin. Conversely, levels of retinol-binding protein 4 (RBP4) were lower in the statin group compared to the non-statin group and controls. Although no significant difference in RBP4 levels between atorvastatin and rosuvastatin users was found, atorvastatin displayed lower RBP4 values. The study also revealed lower C-reactive protein (CRP) levels in the statin group, primarily in the rosuvastatin subgroup, compared to the non-statin group. Conclusion : Statin therapy increased PCSK9 levels, with a more pronounced rise observed in patients treated with rosuvastatin than atorvastatin. Statin therapy proved protective by reducing RBP4 and CRP levels in dyslipidemic nondiabetic patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
12秒前
科研通AI65的应助被萧雨墨采纳,获得10
15秒前
张阳发布了新的文献求助10
17秒前
22秒前
22秒前
22秒前
复杂的万恶完成签到,获得积分10
24秒前
认真的龙猫完成签到 ,获得积分10
26秒前
31秒前
贱小贱完成签到,获得积分0
31秒前
me6363发布了新的文献求助10
36秒前
139完成签到 ,获得积分10
41秒前
无极微光的应助被行必至采纳,获得20
49秒前
科研通AI6.2的应助被萧雨墨采纳,获得10
56秒前
飘逸的安珊完成签到,获得积分10
1分钟前
1分钟前
飞快的不尤完成签到,获得积分10
1分钟前
Jazz33333333完成签到,获得积分10
1分钟前
1874发布了新的文献求助10
1分钟前
shentaii完成签到,获得积分0
1分钟前
果枳完成签到,获得积分10
1分钟前
行必至完成签到,获得积分20
1分钟前
萧雨墨发布了新的文献求助10
1分钟前
香蕉觅云的应助被1874采纳,获得10
1分钟前
张阳发布了新的文献求助10
2分钟前
萧雨墨发布了新的文献求助10
2分钟前
情怀的应助被Lihedou采纳,获得10
2分钟前
2分钟前
2分钟前
Lihedou发布了新的文献求助10
2分钟前
萧雨墨发布了新的文献求助10
2分钟前
Maestro_S的应助被abc采纳,获得10
2分钟前
2分钟前
Jun的应助被科研通管家采纳,获得10
2分钟前
2分钟前
Jun的应助被科研通管家采纳,获得10
2分钟前
科研通AI65的应助被高速公鹿采纳,获得10
2分钟前
kyokyoro完成签到,获得积分10
2分钟前
在水一方的应助被渟柠采纳,获得20
2分钟前
wsws完成签到 ,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190117
求助须知:如何正确求助?哪些是违规求助? 9577222
关于积分的说明 21852176
捐赠科研通 7788406
什么是DOI,文献DOI怎么找? 3436259
关于科研通互助平台的介绍 2559994
邀请新用户注册赠送积分活动 2482862